Cargando…
Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction
Chronic obstructive pulmonary disease (COPD) has a 3-year mortality rate up to 37%, 2–6 times higher than the general population. We present evidence supporting pharmacological therapies to improve patient life expectancy, focusing on inhaled corticosteroids (ICSs) combined with long-acting bronchod...
Autores principales: | Celi, Alessandro, Latorre, Manuela, Paggiaro, Pierluigi, Pistelli, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127735/ https://www.ncbi.nlm.nih.gov/pubmed/34035887 http://dx.doi.org/10.1177/20406223211014028 |
Ejemplares similares
-
Symptom versus exacerbation control: an evolution in GINA guidelines?
por: Latorre, Manuela, et al.
Publicado: (2023) -
Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction
por: Cianchetti, Silvana, et al.
Publicado: (2019) -
Pulmonary Embolism after Relief of Urinary Obstruction
por: Sakamoto, Sumie, et al.
Publicado: (2021) -
Comorbidities are associated with different features of severe asthma
por: Novelli, Federica, et al.
Publicado: (2018) -
Better with Time: Reductions in Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Blagev, Denitza P.
Publicado: (2020)